Ulf Wiinberg

Insider Reports History

Owner filing signature: Ulf Wiinberg
Transaction evidence: Report rows are grouped by the transaction date disclosed in the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Ulf Wiinberg

Form 4 holding Director

MiNK Therapeutics, Inc.

Security class: Common Stock
Shares / value: 27,830
Estimated value: $307,521
Report date: 02 Mar 2026
Price: $11.05
Ownership: Indirect

Form 4 holding Director

MiNK Therapeutics, Inc.

Security class: Common Stock
Shares / value: 22,650
Estimated value: $238,504
Report date: 01 Jun 2026
Price: $10.53
Ownership: Direct

Form 4 holding Director

AGENUS INC

Security class: Deferred Stock Units
Shares / value: 19,501
Estimated value: $113,884
Report date: 01 Oct 2024
Price: $5.84
Ownership: Direct
Underlying class: Common Stock
Underlying amount

Form 4 holding Director

AGENUS INC

Security class: Common Stock
Shares / value: 124,063
Estimated value: $79,400
Report date: 15 Nov 2023
Price: $0.6400
Ownership: Direct

Form 4 holding Director

MiNK Therapeutics, Inc.

Security class: Stock Option (Right to Buy)
Shares / value: 5,395
Estimated value
Report date: 02 Jan 2026
Price
Ownership: Direct
Underlying class: Common Stock
Underlying amount

Form 4 holding Director

AGENUS INC

Security class: Stock Option
Shares / value: 5,000
Estimated value
Report date: 05 Feb 2024
Price
Ownership: Direct
Underlying class: Common Stock
Underlying amount

Insider Reports Filed by Ulf Wiinberg

4 INKT

MiNK Therapeutics, Inc.

Report period: 02 Mar 2026
Transactions: 2
Transaction value: $0
Accepted by SEC: 02 Jun 2026, 16:05
Role: Director
Next action: Open filing details

4 INKT

MiNK Therapeutics, Inc.

Report period: 02 Jan 2026
Transactions: 1
Transaction value: $0
Accepted by SEC: 06 Jan 2026, 17:24
Role: Director
Next action: Open filing details

4 INKT

MiNK Therapeutics, Inc.

Report period: 01 Dec 2025
Transactions: 1
Transaction value: +$14,007
Accepted by SEC: 03 Dec 2025, 16:10
Role: Director
Next action: Open filing details

4 INKT

MiNK Therapeutics, Inc.

Report period: 09 Sep 2025
Transactions: 1
Transaction value: $0
Accepted by SEC: 11 Sep 2025, 16:05
Role: Director
Next action: Open filing details

4 INKT

MiNK Therapeutics, Inc.

Report period: 02 Sep 2025
Transactions: 1
Transaction value: +$14,012
Accepted by SEC: 03 Sep 2025, 17:33
Role: Director
Next action: Open filing details

4 INKT

MiNK Therapeutics, Inc.

Report period: 02 Jun 2025
Transactions: 1
Transaction value: +$14,003
Accepted by SEC: 04 Jun 2025, 16:05
Role: Director
Next action: Open filing details

4 INKT

MiNK Therapeutics, Inc.

Report period: 03 Mar 2025
Transactions: 1
Transaction value: +$14,002
Accepted by SEC: 05 Mar 2025, 16:05
Role: Director
Next action: Open filing details

4 INKT

MiNK Therapeutics, Inc.

Report period: 01 Dec 2024
Transactions: 1
Transaction value: +$14,947
Accepted by SEC: 03 Dec 2024, 10:35
Role: Director
Next action: Open filing details

4 AGEN

AGENUS INC

Report period: 01 Oct 2024
Transactions: 1
Transaction value: $0
Accepted by SEC: 03 Oct 2024, 08:40
Role: Director
Next action: Open filing details

4 INKT

MiNK Therapeutics, Inc.

Report period: 03 Sep 2024
Transactions: 1
Transaction value: +$15,002
Accepted by SEC: 05 Sep 2024, 08:22
Role: Director
Next action: Open filing details

4 AGEN

AGENUS INC

Report period: 01 Jul 2024
Transactions: 1
Transaction value: $0
Accepted by SEC: 01 Jul 2024, 16:05
Role: Director
Next action: Open filing details

4 INKT

MiNK Therapeutics, Inc.

Report period: 03 Jun 2024
Transactions: 1
Transaction value: +$14,926
Accepted by SEC: 05 Jun 2024, 14:24
Role: Director
Next action: Open filing details

4 AGEN

AGENUS INC

Report period: 01 Apr 2024
Transactions: 1
Transaction value: $0
Accepted by SEC: 01 Apr 2024, 16:20
Role: Director
Next action: Open filing details

4 INKT

MiNK Therapeutics, Inc.

Report period: 01 Mar 2024
Transactions: 1
Transaction value: +$15,000
Accepted by SEC: 05 Mar 2024, 18:00
Role: Director
Next action: Open filing details

4 AGEN

AGENUS INC

Report period: 05 Feb 2024
Transactions: 1
Transaction value: $0
Accepted by SEC: 22 Apr 2024, 16:05
Role: Director
Next action: Open filing details

4 AGEN

AGENUS INC

Report period: 02 Jan 2024
Transactions: 1
Transaction value: $0
Accepted by SEC: 04 Jan 2024, 06:05
Role: Director
Next action: Open filing details

4 INKT

MiNK Therapeutics, Inc.

Report period: 01 Dec 2023
Transactions: 1
Transaction value: +$15,001
Accepted by SEC: 05 Dec 2023, 18:05
Role: Director
Next action: Open filing details

4 AGEN

AGENUS INC

Report period: 15 Nov 2023
Transactions: 1
Transaction value: +$19,000
Accepted by SEC: 17 Nov 2023, 16:22
Role: Director
Next action: Open filing details

4 AGEN

AGENUS INC

Report period: 02 Oct 2023
Transactions: 1
Transaction value: $0
Accepted by SEC: 04 Oct 2023, 17:01
Role: Director
Next action: Open filing details

4 INKT

MiNK Therapeutics, Inc.

Report period: 01 Sep 2023
Transactions: 1
Transaction value: +$14,001
Accepted by SEC: 06 Sep 2023, 17:00
Role: Director
Next action: Open filing details

4 AGEN

AGENUS INC

Report period: 03 Jul 2023
Transactions: 1
Transaction value: $0
Accepted by SEC: 06 Jul 2023, 16:30
Role: Director
Next action: Open filing details

4 INKT

MiNK Therapeutics, Inc.

Report period: 14 Jun 2023
Transactions: 1
Transaction value: $0
Accepted by SEC: 16 Jun 2023, 20:03
Role: Director
Next action: Open filing details

4 INKT

MiNK Therapeutics, Inc.

Report period: 01 Jun 2023
Transactions: 1
Transaction value: +$14,001
Accepted by SEC: 02 Jun 2023, 19:40
Role: Director
Next action: Open filing details

4 AGEN

AGENUS INC

Report period: 03 Apr 2023
Transactions: 1
Transaction value: $0
Accepted by SEC: 03 Apr 2023, 15:58
Role: Director
Next action: Open filing details

4 INKT

MiNK Therapeutics, Inc.

Report period: 01 Mar 2023
Transactions: 1
Transaction value: +$14,001
Accepted by SEC: 03 Mar 2023, 14:23
Role: Director
Next action: Open filing details

4 AGEN

AGENUS INC

Report period: 08 Jan 2023
Transactions: 1
Transaction value: $0
Accepted by SEC: 09 Jan 2023, 18:02
Role: Director
Next action: Open filing details

4 AGEN

AGENUS INC

Report period: 03 Jan 2023
Transactions: 1
Transaction value: $0
Accepted by SEC: 04 Jan 2023, 10:25
Role: Director
Next action: Open filing details

4 INKT

MiNK Therapeutics, Inc.

Report period: 01 Dec 2022
Transactions: 1
Transaction value: +$14,000
Accepted by SEC: 05 Dec 2022, 17:27
Role: Director
Next action: Open filing details

4 AGEN

AGENUS INC

Report period: 03 Oct 2022
Transactions: 1
Transaction value: $0
Accepted by SEC: 05 Oct 2022, 13:09
Role: Director
Next action: Open filing details

4 INKT

MiNK Therapeutics, Inc.

Report period: 15 Sep 2022
Transactions: 1
Transaction value: +$28,003
Accepted by SEC: 19 Sep 2022, 19:06
Role: Director
Next action: Open filing details

4 INKT

MiNK Therapeutics, Inc.

Report period: 18 Jul 2022
Transactions: 2
Transaction value: +$27,646
Accepted by SEC: 21 Jul 2022, 15:21
Role: Director
Next action: Open filing details

4 AGEN

AGENUS INC

Report period: 01 Jul 2022
Transactions: 1
Transaction value: $0
Accepted by SEC: 06 Jul 2022, 15:50
Role: Director
Next action: Open filing details

4 AGEN

AGENUS INC

Report period: 01 Apr 2022
Transactions: 1
Transaction value: $0
Accepted by SEC: 05 Apr 2022, 18:26
Role: Director
Next action: Open filing details

4 INKT

MiNK Therapeutics, Inc.

Report period: 09 Mar 2022
Transactions: 1
Transaction value: $0
Accepted by SEC: 11 Mar 2022, 15:08
Role: Director
Next action: Open filing details

4 AGEN

AGENUS INC

Report period: 04 Feb 2022
Transactions: 1
Transaction value: $0
Accepted by SEC: 08 Feb 2022, 17:10
Role: Director
Next action: Open filing details

4 AGEN

AGENUS INC

Report period: 03 Jan 2022
Transactions: 1
Transaction value: $0
Accepted by SEC: 05 Jan 2022, 14:24
Role: Director
Next action: Open filing details

3 INKT

MiNK Therapeutics, Inc.

Report period: 13 Oct 2021
Transactions: 0
Transaction value: $0
Accepted by SEC: 20 Oct 2021, 18:59
Role: Director
Next action: Open filing details

4 AGEN

AGENUS INC

Report period: 01 Oct 2021
Transactions: 1
Transaction value: $0
Accepted by SEC: 05 Oct 2021, 19:13
Role: Director
Next action: Open filing details

4 AGEN

AGENUS INC

Report period: 16 Jun 2021
Transactions: 1
Transaction value: $0
Accepted by SEC: 21 Jun 2021, 16:17
Role: Director
Next action: Open filing details

4 AGEN

AGENUS INC

Report period: 15 Jun 2021
Transactions: 2
Transaction value: $0
Accepted by SEC: 02 Jul 2021, 18:00
Role: Director
Next action: Open filing details

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .